Biomedis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 558,745 | 1,000,255 | 771,296 | 1,087,610 | 444,509 | 3,362 | 28,731 | 11,595 |
| Profit before tax | 19,275 | 63,916 | 27,395 | 50,857 | 49,614 | -23,997 | -20,195 | -7,690 |
| Net profit | 16,384 | 54,308 | 23,270 | 43,228 | 42,138 | -23,997 | -20,195 | -7,690 |
| Equity | 25,981 | 66,172 | 88,736 | 122,552 | 121,160 | 97,162 | 74,615 | -3,664 |
| Liabilities | 53,141 | 46,908 | 52,465 | 53,534 | 39,774 | 41,802 | 12,875 | 8,434 |
| Non-current assets | 9,144 | 161 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 69,978 | 112,919 | 141,201 | 176,086 | 160,934 | 138,964 | 87,490 | 4,770 |
| Total assets | 79,122 | 113,080 | 141,201 | 176,086 | 160,934 | 138,964 | 87,490 | 4,770 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 5,835 | 5,866 | 6,040 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +279.3% | +79.0% | -22.9% | +41.0% | -59.1% | -99.2% | +754.6% | -59.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 20.7% | 48.0% | 16.5% | 24.5% | 26.2% | -17.3% | -23.1% | -161.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 63.1% | 82.1% | 26.2% | 35.3% | 34.8% | -24.7% | -27.1% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.9% | 5.4% | 3.0% | 4.0% | 9.5% | -713.8% | -70.3% | -66.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.4% | 6.4% | 3.6% | 4.7% | 11.2% | -713.8% | -70.3% | -66.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.0 | 0.7 | 0.6 | 0.4 | 0.3 | 0.4 | 0.2 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 279,373 | 500,128 | 385,648 | 501,966 | 222,255 | 1,681 | 14,366 | 5,798 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biomedis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-26 | 2026-08-27 | 80.08 |
| 2026-08-23 | 2026-08-23 | 80.08 |
| 2026-08-19 | 2026-08-19 | 80.08 |
| 2026-08-16 | 2026-08-17 | 49.42 |
| 2026-07-23 | 2026-08-14 | 49.42 |
| 2026-07-19 | 2026-07-22 | 48.87 |
| 2026-07-16 | 2026-07-17 | 48.87 |
| 2026-07-15 | 2026-07-15 | 18.21 |
| 2026-06-16 | 2026-07-14 | 48.87 |
| 2026-06-11 | 2026-06-15 | 18.21 |
| 2026-05-17 | 2026-06-08 | 18.21 |
| 2026-02-18 | 2026-03-02 | 2.85 |
| 2025-07-24 | 2025-08-11 | 118.77 |
| 2025-07-16 | 2025-07-23 | 115.96 |
| 2025-07-15 | 2025-07-15 | 52.98 |
| 2025-06-17 | 2025-07-14 | 115.96 |
| 2025-06-14 | 2025-06-16 | 52.98 |
| 2025-06-11 | 2025-06-13 | 115.96 |
| 2025-06-08 | 2025-06-09 | 115.96 |
| 2025-05-16 | 2025-06-04 | 115.96 |
| 2025-05-15 | 2025-05-15 | 52.98 |
| 2025-05-04 | 2025-05-14 | 115.96 |
| 2025-04-16 | 2025-04-30 | 115.96 |
| 2025-02-10 | 2025-02-10 | 0.45 |
| 2025-01-16 | 2025-02-03 | 0.45 |
| 2025-01-02 | 2025-01-14 | 0.45 |
| 2024-12-22 | 2024-12-31 | 0.45 |
| 2024-12-17 | 2024-12-20 | 0.45 |
| 2024-11-18 | 2024-12-12 | 0.45 |
| 2024-10-24 | 2024-11-14 | 0.45 |
| 2024-08-19 | 2024-08-25 | 155.59 |
| 2024-07-24 | 2024-08-18 | 0.86 |
| 2024-06-18 | 2024-06-26 | 139.64 |
| 2024-05-16 | 2024-06-13 | 0.64 |
| 2024-04-25 | 2024-05-13 | 0.64 |
| 2024-04-23 | 2024-04-24 | 155.37 |
| 2024-04-16 | 2024-04-22 | 154.73 |
| 2024-02-19 | 2024-02-28 | 153.24 |
| 2023-03-16 | 2023-03-23 | 154.09 |
| 2023-02-17 | 2023-03-15 | 1.90 |
| 2023-02-06 | 2023-02-13 | 1.90 |
| 2023-01-23 | 2023-02-03 | 1.90 |
| 2022-12-16 | 2022-12-28 | 147.98 |
| 2022-12-14 | 2022-12-15 | 0.97 |
| 2022-11-21 | 2022-12-13 | 147.98 |
| 2022-11-17 | 2022-11-18 | 147.98 |
| 2022-10-31 | 2022-11-16 | 0.97 |
| 2022-10-18 | 2022-10-30 | 0.53 |
| 2022-09-16 | 2022-10-13 | 0.53 |
| 2022-08-23 | 2022-09-13 | 0.53 |
| 2022-07-25 | 2022-08-11 | 0.53 |
| 2022-07-18 | 2022-07-24 | 147.01 |
| 2022-06-16 | 2022-06-26 | 147.01 |
| 2022-02-17 | 2022-03-03 | 0.08 |
| 2022-01-28 | 2022-02-13 | 0.08 |
Biomedis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-04 | 2025-06-10 | 44.03 |
| 2025-06-02 | 2025-06-03 | 5295.32 |
| 2025-05-31 | 2025-06-01 | 5279.7 |
| 2025-05-29 | 2025-05-30 | 5279.89 |
| 2025-05-24 | 2025-05-28 | 5309.89 |
| 2025-05-20 | 2025-05-23 | 5281.29 |
| 2025-05-17 | 2025-05-19 | 5308.29 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biomedis, UAB (code 304425667) is a Private Limited Liability Company engaged in wholesale of solid fuel. In 2025, revenue declined to €11.6K from €28.7K in 2024, after €3.4K in 2023. The company remained loss-making, although the net loss narrowed to €7.7K in 2025 from €20.2K in 2024 and €24.0K in 2023. The 2025 profit margin was -66.3%, reflecting continued pressure on profitability. The balance sheet also weakened materially: total assets fell to €4.8K at the end of 2025 from €87.5K a year earlier and €139.0K in 2023. Equity turned negative at -€3.7K, while liabilities stood at €8.4K. Asset turnover was 2.43x, indicating revenue generation from a very small asset base. Revenue per employee was €5.8K and loss per employee was €3.8K, which points to limited operating scale. Ratios such as ROE and ROA are heavily distorted by the very small and negative equity base and should be interpreted cautiously.